news
Trioxacarcins synthesised as a potent anti-cancer agent
11 March 2016 | By Victoria White
Trioxacarcins disrupt the replication of cancer cells by binding and chemically modifying their genetic material...
List view / Grid view
Oncology
Oncology is a branch of medicine that deals with the prevention, diagnosis and treatment of cancer.
news
Psaptides attack ovarian cancer on two fronts
10 March 2016 | By Victoria White
These findings from a new study suggest that psaptides could serve as a promising template for the development of treatment options directed against ovarian and maybe other cancers...
news
Research identifies first step in design of new anti-cancer drugs
10 March 2016 | By Victoria White
Researchers have identified a first step in the design of a new generation of anti-cancer drugs that include an agent to inhibit resistance to their effectiveness...
news
PhoreMost and The Wistar team up to identify targets in cancer, immunotherapy and aging
10 March 2016 | By Victoria White
PhoreMost has entered into an alliance with The Wistar Institute to identify and de-orphan novel targets in cancer, aging and the immune system...
news
Ipsen and PeptiMimesis in oncology peptide partnership
10 March 2016 | By Victoria White
Ipsen and PeptiMimesis have signed a research partnership and a licensing option for the development and marketing of novel therapeutic peptides in oncology...
news
Researchers identify PHGDH inhibitor to target serine biosynthesis in cancer
8 March 2016 | By Victoria White
Researchers have shown that CBR-5884 was able to inhibit cell proliferation of breast cancer and melanoma cells lines that overexpress PHGDH...
news
New insights reported on the function of BRCA1 in breast cancer
7 March 2016 | By Victoria White
Scientists have provided a deeper insight into how BRCA1 functions in normal breast tissue and how its loss results in breast cancer...
news
Researchers find Achilles’ heel of acute lymphoblastic leukaemia
2 March 2016 | By Victoria White
Researchers have discovered that a GSK-J4 can kill acute lymphoblastic leukaemia that involves the TAL-1 gene...
news
Regen completes preclinical experimentation for its NR2F6 checkpoint inhibitor
26 February 2016 | By Victoria White
Regen has recently filed two patent applications covering the molecular pathways activated by NR2F6 silencing...
news
Adaptive therapy inhibits chemo-resistance in study
25 February 2016 | By Victoria White
Adaptive therapy is based on evolutionary principals and aims to keep resistant cells in check by maintaining a population of chemo-sensitive cells...
news
Pancreatic cancer identified as four separate diseases
24 February 2016 | By Victoria White
A study has revealed that pancreatic cancer is actually four separate diseases, each with different genetic triggers and survival rates, paving the way for more accurate diagnoses and treatments...
news
OncoQR ML’s TYG100 induces strong immune response in pancreatic cancer
23 February 2016 | By Victoria White
In a highly relevant non-human primate model TYG100 was able to induce a strong and clinically relevant immune response...
article
Directing a weaponised attack on cancer with Natural Killer Receptor T-Cells
23 February 2016 | By Dr Frédéric Lehmann, VP Immuno-Oncology, Celyad
Natural killer receptor T-cells have the potential to become a real game changing treatment for patients with cancer. Here, Dr Frédéric Lehmann, VP Immuno-Oncology, Celyad, discusses this new cancer fighting technology...
news
Desktop Genetics receives grant for site-specific epigenetic CRISPR editing
23 February 2016 | By Victoria White
Given the key role of epigenetics in all tumour types, Desktop Genetics' research has wide potential applications across all histological types of cancer...
news
New nanoparticle has potential to treat ocular cancer
19 February 2016 | By Victoria White
Researchers have developed a new nanoparticle that uses a tumour cell's protective mechanism against itself - short-circuiting tumour cell metabolism and killing tumour cells...
